These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20133228)

  • 1. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases.
    Huang YQ; Xu F; Yang JM; Huang B
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):44-8. PubMed ID: 20133228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.
    Park CH; Chung JW; Jang SJ; Chung MJ; Bang S; Park SW; Song SY; Chung JB; Park JY
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1306-11. PubMed ID: 22414232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
    Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
    Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long-term results].
    Bartolozzi C; Lencioni R; Armillotta N
    Radiol Med; 1997; 94(1-2):19-23. PubMed ID: 9424645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy.
    Tateishi H; Oi H; Masuda N; Yano H; Matsui S; Kinuta M; Maruyama H; Yayoi E; Okamura J
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].
    Lin Z; Ren Z; Xia J
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):315-7. PubMed ID: 11778559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive sequential interventional therapy for hepatocellular carcinoma.
    Zhang L; Fan WJ; Huang JH; Li CX; Zhao M; Wang LG; Tang T
    Chin Med J (Engl); 2009 Oct; 122(19):2292-8. PubMed ID: 20079128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous cryoablation after chemoembolization of liver carcinoma: report of 34 cases.
    Qian GJ; Chen H; Wu MC
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):520-4. PubMed ID: 14627512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
    Takano S; Watanabe Y; Ohishi H; Kono S; Nakamura M; Kubota N; Iwai S
    Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
    Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
    J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.